Resultados da pesquisa - Rossella Fioravanti

LSD1 inhibitors for cancer treatment: Focus on multi-target agents and compounds in clinical trials Por Beatrice Noce, Elisabetta Di Bello, Rossella Fioravanti, Antonello Mai, Antonello Mai

Connect to this object online.

Selenium-Containing Agents Acting on Cancer-A New Hope? Por Sabrina Garbo, Silvia Di Giacomo, Dorota Łażewska, Ewelina Honkisz-Orzechowska, Antonella Di Sotto, Rossella Fioravanti, Clemens Zwergel, Cecilia Battistelli

Connect to this object online.

CDK9 as a Valuable Target in Cancer: From Natural Compounds Inhibitors to Current Treatment in Pediatric Soft Tissue Sarcomas Por Matteo Cassandri, Rossella Fioravanti, Silvia Pomella, Sergio Valente, Dante Rotili, Giada Del Baldo, Biagio De Angelis, Rossella Rota, Antonello Mai

Connect to this object online.

Pharmacological Activation of SIRT3 Modulates the Response of Cancer Cells to Acidic pH Por Michele Aventaggiato, Tania Arcangeli, Enza Vernucci, Federica Barreca, Luigi Sansone, Laura Pellegrini, Elena Pontemezzo, Sergio Valente, Rossella Fioravanti, Matteo Antonio Russo, Antonello Mai, Marco Tafani

Connect to this object online.

Heterocycle-containing tranylcypromine derivatives endowed with high anti-LSD1 activity Por Rossella Fioravanti, Veronica Rodriguez, Jonatan Caroli, Ugo Chianese, Rosaria Benedetti, Elisabetta Di Bello, Beatrice Noce, Clemens Zwergel, Davide Corinti, Dolores Viña, Lucia Altucci, Andrea Mattevi, Sergio Valente, Antonello Mai

Connect to this object online.